QT Imaging (QTI)

The company’s principal product is the QT Breast Scanner, a system designed for breast imaging without ionising radiation or breast compression. This differentiates the platform from mammography, which remains a standard screening method but can involve discomfort and radiation exposure. QT Imaging’s approach uses transmission ultrasound techniques to generate three-dimensional images and quantitative information that may help clinicians evaluate breast tissue. The company also offers QTviewer, software used to view and analyse images produced by its systems.

QT Imaging operates in a highly regulated and competitive market that includes established medical imaging modalities such as mammography, ultrasound, MRI, and CT. Adoption of new imaging technology depends on clinical evidence, regulatory clearances, reimbursement pathways, workflow fit, and physician confidence. Hospitals, imaging centres, and specialist clinics generally assess new systems based on diagnostic usefulness, patient experience, cost, throughput, and integration with existing care practices.

As a public company, QT Imaging is defined by its effort to bring a specialised sound-based imaging platform into broader clinical use. Its business is linked to product commercialisation, customer installations, software support, and continued development of medical imaging applications.